Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1539 Activators

KIAA1539 activators encompass a diverse array of compounds that engage with several signaling pathways, ultimately potentiating the activity of this protein through distinct mechanisms. For instance, certain activators target the synthesis of cyclic AMP (cAMP), a crucial second messenger in cellular signaling. By activating adenylyl cyclase or inhibiting phosphodiesterases, these compounds increase intracellular cAMP levels, which could indirectly enhance KIAA1539 activity by engaging downstream components of the cAMP-dependent signaling cascade. Additionally, the use of cAMP analogs serves a similar purpose, mimicking the effects of natural cAMP and thereby potentially upregulating KIAA1539 activity within the cell. Furthermore, the modulation of protein kinase C (PKC) through specific activators influences a variety of cellular functions, and such modulation may alter the activity of KIAA1539 via PKC-mediated signaling pathways.

Other activators exert their effects by manipulating intracellular calcium levels. Calcium ionophores, for example, facilitate the influx of calcium ions, which could have a substantial impact on calcium-dependent signaling processes that indirectly affect the function of KIAA1539. Similarly, G-protein signaling is another avenue through which KIAA1539 activity could be modulated. Using non-hydrolyzable analogs of GTP, such as GTPγS, may lead to the persistent activation of G-proteins and the consequent engagement of signaling pathways that bear upon the activity of KIAA1539. In addition, compounds that alter the cellular redox state or interact with components of the Wnt/β-catenin signaling pathway may also modulate the activity of KIAA1539.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist that elevates cAMP, indirectly promoting KIAA1539 activity via cAMP signaling.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-selective phosphodiesterase inhibitor, raises cAMP levels, possibly supporting KIAA1539 activation.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PKC activator that could modulate KIAA1539 activity by influencing protein kinase C-mediated signaling pathways.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

cAMP analog that could enhance KIAA1539 activity by mimicking the effects of cAMP in signaling pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Calcium ionophore that raises intracellular calcium, potentially affecting KIAA1539 through calcium-dependent mechanisms.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A calcium ionophore that could indirectly activate KIAA1539 by altering calcium signaling.

Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt

94825-44-2sc-202639
10 mg
$465.00
(0)

Non-hydrolyzable GTP analog, could activate G-proteins and influence KIAA1539 activity downstream of G-protein signaling.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Adrenergic receptor agonist which increases cAMP levels, might indirectly activate KIAA1539 through cAMP-dependent pathways.

Nicotinamide riboside

1341-23-7sc-507345
10 mg
$411.00
(0)

NAD+ precursor that may enhance KIAA1539 function by influencing cellular redox states and related signaling pathways.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

GSK-3 inhibitor that could affect KIAA1539 by modifying Wnt signaling and associated downstream effects.